Replies to post #55760 on Cytodyn Inc (CYDY)

[Blane]

“Rebuttal With Facts

The allegations of the Culper Report were so off the wall there really isn’t a way to address all the falsehoods regurgitated in the report. Here are some humorous ones.

They call Nader the Chief Promotions Officer

They call him a criminal because he started a business and shut it down

They say Circulating Tumor Cells (CTC’s) are not a surrogate endpoint yet its the 5th outcome listed on the clinical trial.

They don’t think he will get FDA approval immediately or BTD yet his drug is shrinking tumors in two months in indications that typically take 6 months to just see stabilization.

They attacked him for getting rid of Pestell who wanted to test for toxicity and delay things.

They made fun of Nader for doing a number of investor videos to keep shareholders informed.

They don’t believe hes working with a real Chinese drug company to solve the Coronavirus outbreak because they think he is looking at the wrong receptor.

They quote an oncologist who indicated that stage 4 patients needed a control arm.

Then they can’t even do math to project annual sales.

Do these allegations sound legitimate or a little far fetched?“
——————————

One thing emerging growth forgot to mention was that there were no names of any Oncologists. Just supposed statements without any people to cite.

This report was swallowed by those who like short stuff.

[The Blue Baron]

Yes, the Culper Report was a hit job-All anonymous. Do you really believe very busy MDs would take time out of their day to speak to someone who wants to short stocks to make a quick profit? It should also be noted that Emerging Growth was compensated $2,500 by CYDY-Your money.

EmergingGrowth.com has been compensated two thousand five hundred dollars in consideration for its work with CytoDyn, Inc. through the date this was published. EmergingGrowth.com may or may not receive additional compensation, details about which can be found in our full disclosure, which can be found here, https://emerginggrowth.com/68272-2939/. You can easily loose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.